Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
311
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup

Laura N. TothDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USA
,
Donald GreenDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USA
,
Jason PetersonDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USA
,
Sophie J. DeharvengtDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USA
,
Francine B. de AbreuDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USA
&
Eric Y. LooDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, NH, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7089-2169
ORCID Icon
Pages 2415-2422 | Received 20 Oct 2018, Accepted 20 Feb 2019, Published online: 18 Apr 2019

References

  • Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506–510.
  • Jan M, Snyder TM, Corces-Zimmerman MR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med. 2012;4:149ra118.
  • Lin TL, Smith BD. Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia. Am J Med Sci. 2011;341:404–408.
  • Schiffer CA. Molecular characterization of AML: a significant advance or just another prognostic factor? Best Pract Res Clin Haematol. 2008;21:621–628.
  • Stone RM. Prognostic factors in AML in relation to (ab)normal karyotype. Best Pract Res Clin Haematol. 2009;22:523–528.
  • Radich JP. Molecular classification of acute myeloid leukemia: are we there yet? JCO. 2008;26:4539–4541.
  • Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 2015;126:9–16.
  • Duque-Afonso J, Cleary ML. The AML salad bowl. Cancer Cell. 2014;25:265–267.
  • Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150:264–278.
  • Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med. 2009;361:1058–1066.
  • Corces-Zimmerman MR, Hong WJ, Weissman IL, et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci USA. 2014;111:2548–2553.
  • Heuser M, Thol F, Ganser A. Clonal hematopoiesis of indeterminate potential. Dtsch Arzteblatt Int. 2016;113:317–322.
  • McKerrell T, Park N, Moreno T, et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 2015;10:1239–1245.
  • Sykes SM, Kokkaliaris KD, Milsom MD, et al. Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia. Exp Hematol. 2015;43:989–992.
  • Luthra R, Chen H, Roy-Chowdhuri S, et al. Next-generation sequencing in clinical molecular diagnostics of cancer: advantages and challenges. Cancers (Basel). 2015;7:2023–2036.
  • McNamara CJ, Panzarella T, Kennedy JA, et al. The mutational landscape of accelerated-and blast-phase myeloproliferative neoplasms impacts patient outcomes. Blood Adv. 2018;2:2658–2671.
  • Greenberg PL, Stone RM, Al-Kali A, et al. Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15:60–87.
  • ClinVar [Internet]. Bethesda (MD): National Center for Biotechnology Information, U.S. National Library of Medicine. [cited 2018 Dec 13]. Available from: https://www.ncbi.nlm.nih.gov/clinvar/
  • COSMIC [Internet]. Cambridgeshire (UK): The Sanger Institute: [updated 2018 Nov 13; cited 2018 Dec 13]. Available from: https://cancer.sanger.ac.uk/cosmic
  • Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–333.
  • Jongen-Lavrencic M, Grob T, Hanekamp D, et al. Molecular minimal residual disease in acute myeloid leukemia. N Engl J Med. 2018;378:1189–1199.
  • Salipante SJ, Fromm JR, Shendure J, et al. Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing. Mod Pathol. 2014;27:1438–1446.
  • Ivey A, Hills RK, Simpson MA, et al. Assessment of minimal residual disease in standard-risk AML. N Engl J Med. 2016;374:422–433.
  • Debarri H, Lebon D, Roumier C, et al. IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association. Oncotarget. 2015;6:42345–42353.
  • O'Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood. 2010;115:2731–2739.
  • Sakaguchi M, Yamaguchi H, Najima Y, et al. Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia. Blood Adv. 2018; 2:2744–2754.
  • Oran B, Cortes J, Beitinjaneh A, et al. Allogeneic transplantation in first remission improves outcomes irrespective of FLT3-ITD allelic ratio in FLT3-ITD-positive acute myelogenous leukemia. Biol Blood Marrow Transplant. 2016;22:1218–1226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.